http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105198960-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-097 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2014-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105198960-B |
| titleOfInvention | Imidazopyridine -6- formyl-Met-AA-OBzl, synthesis, activity and application |
| abstract | The invention discloses 4 kinds of 3H imidazos [4,5 c] 6 formyl Met AA benzyl esters and preparation method thereof of pyridine, disclose their inhibiting effect to tumour growth, their antithrombotic acitivity is further disclosed, thus the invention discloses their dual-uses as antitumor drug and antithrombotic reagent. |
| priorityDate | 2014-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 66.